PAHC FY 2016 Earnings Report — Phibro Animal Health Corporation Revenue & Financial Results | Market Cap Arena

Phibro Animal Health CorporationPAHC

FY 2016 Earnings

Reported August 29, 2016

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2016	Prior Q	FY 2015	QoQ Change	YoY Change
Revenue	$752M	—	$749M	—	0.4%
Op. Income	$86M	—	$88M	—	-2.2%
Gross Margin	31.8%	—	31.6%	—	0.2pp
Net Margin	11.0%	—	8.1%	—	3.0pp
EPS (Diluted)	$2.07	—	$1.51	—	37.1%
Free Cash Flow	$866.0K	—	$49M	—	-98.2%

Revenue Flow

Item	Amount
REVENUE	$752M
Cost of Revenue	$513M
GROSS PROFIT	$239M
R&D Expenses	$11M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$153M
Other Expenses	$0
Operating Expenses	$153M
Cost & Expenses	$666M
OPERATING INCOME	$86M
Interest Income	$256.0K
Interest Expense	$17M
Other Income/Expenses	-$19M
INCOME BEFORE TAX	$77M
Income Tax Expense	-$6M
Net Income from Continuing Ops	$83M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$83M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$83M
D&A	$23M
EBIT	$94M
EBITDA	$117M
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$752M
Cost of Revenue	$513M
GROSS PROFIT	$239M
R&D Expenses	$11M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$153M
Other Expenses	$0
Operating Expenses	$153M
Cost & Expenses	$666M
OPERATING INCOME	$86M
Interest Income	$256.0K
Interest Expense	$17M
Other Income/Expenses	-$19M
INCOME BEFORE TAX	$77M
Income Tax Expense	-$6M
Net Income from Continuing Ops	$83M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$83M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$83M
D&A	$23M
EBIT	$94M
EBITDA	$117M
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$83M
Depreciation & Amortization	$23M
Stock-Based Compensation	$0
Deferred Income Tax	-$22M
Other Non-Cash Items	$7M
Change in Working Capital	-$46M
OPERATING CASH FLOW	$37M
Capital Expenditure	-$36M
Acquisitions (Net)	-$47M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$137.0K
NET CASH FROM INVESTING	-$83M
Net Debt Issuance	$62M
Common Stock Repurchased	$0
Common Dividends Paid	-$16M
Other Financing Activities	$0
NET CASH FROM FINANCING	$50M
FREE CASH FLOW	$866.0K
Net Change in Cash	$4M

Balance Sheet

Item	Amount
Cash & Equivalents	$34M
Short-Term Investments	$0
Net Receivables	$124M
Inventory	$168M
Other Current Assets	$18M
TOTAL CURRENT ASSETS	$343M
PP&E (Net)	$127M
Goodwill	$21M
Intangible Assets	$60M
Long-Term Investments	$9M
Tax Assets	$28M
Other Non-Current Assets	$22M
TOTAL NON-CURRENT ASSETS	$268M
TOTAL ASSETS	$610M
Account Payables	$60M
Short-Term Debt	$3M
Deferred Revenue	$0
Other Current Liabilities	$35M
TOTAL CURRENT LIABILITIES	$109M
Long-Term Debt	$347M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$8M
Other Non-Current Liabilities	$53M
TOTAL NON-CURRENT LIABILITIES	$409M
TOTAL LIABILITIES	$520M
Common Stock	$4.0K
Additional Paid-In Capital	$118M
Retained Earnings	$34M
Treasury Stock	$0
Accum. Other Comp. Income	-$62M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$90M
Minority Interest	$0
TOTAL EQUITY	$90M
TOTAL LIABILITIES & EQUITY	$610M
Total Debt	$353M
Net Debt	$319M